Sick sinus syndrome, atrioventricular block, congestive heart failure, ventricular tachycardia, ventricular fibrillation, and othe diseases requiring cardiac implantable electric devices
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects all meet the criteria showen below: 1) Those who receive cardiac implantable electric devices requiring more than one lead. 2) Adult patient 3) Those who give a written consent for the present study
Exclusion criteria
Exclusion criteria: 1) Those who is not able to give a written consent 2) Patients who already received device lead implantation from the target cephalic vein 3) Other subjects whom responsible doctors assume inappropriate for the study 4) Patients whose hemoglobin concentration is lower than the normal limits defined by the hospital
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The alteration of hemorrhaging after the ligation compared to preligation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) The alteration of lead maneuvability after the ligation compared to preligation in each patient 2) Success of two leads implantation through same cephalic vein 3) Comparison of hemorraging against control group | — |
Countries
Japan
Contacts
Chiba University Graduate School of Medicine Department of Cardiovascular Medicine